1. Home
  2. LIXT vs HKIT Comparison

LIXT vs HKIT Comparison

Compare LIXT & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$3.01

Market Cap

25.3M

Sector

Health Care

ML Signal

HOLD

HKIT

Hitek Global Inc.

HOLD

Current Price

$0.04

Market Cap

25.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIXT
HKIT
Founded
2005
1996
Country
United States
China
Employees
4
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
25.3M
25.2M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
LIXT
HKIT
Price
$3.01
$0.04
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
37.9K
42.5M
Earning Date
05-11-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$0.03
52 Week High
$6.09
$4.21

Technical Indicators

Market Signals
Indicator
LIXT
HKIT
Relative Strength Index (RSI) 52.40 21.41
Support Level $2.97 N/A
Resistance Level $3.30 $1.48
Average True Range (ATR) 0.28 0.21
MACD 0.04 -0.08
Stochastic Oscillator 63.24 0.77

Price Performance

Historical Comparison
LIXT
HKIT

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About HKIT Hitek Global Inc.

Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.

Share on Social Networks: